chrisvoncsefalvay/vaers-outcomes huggingface dataset:
chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced CHILLS (chills) and PYREXIA (fever). At the time of the report, CHILLS (chills) and PYREXIA (fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2021, SARS-CoV-2 test: posetive Positive.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  No concomitant product information was provided.  No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Causality for COVID-19 test positive is not applicable.
Patient received Pfizer COVID vaccine on 2/23/21 and 3/15/21. On 9/22/21, patient was admitted to our facility with  acute respiratory failure with hypoxia, COVID and superimposed bacterial pneumonia, acute pulmonary edema, hypertensive emergency, afib RVR, and acute metabolic encephalopathy.  Patient tested positive for COVID on admission.  She was placed in CCU until 9/23/21, then transferred to med/surg unit and still admitted as of today (9/25/21).
Administered booster dose of Moderna (blue top)).  Person should have received Moderna Bivalent booster (blue top).  No adverse event occurred.
Ears red, welts all over body, red rash on back and torso, face red rash, eyes swollen, and began wheezing. Taken to ER - given Benadryl and steroids.
blood clots in both lungs; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 77 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 10Feb2021 11:30 (Lot number: EL9264) at the age of 77 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: The patient experienced blood clots in both lungs on 01Mar2021, and resulted in hospitalization from 01Mar2021 to 02Mar2021. It was reported that the patient received first dose on 10Feb2021 and the second dose on 03Mar2021. Two days prior to the second dose he was admitted to hospital for blood clots in both lungs; they kept him over night. A CAT scan was done and determined he did have blood clots. At the time he was concerned or thought it was related to the vaccine. Then the day after getting out of the hospital got the second dose. On 02Sep2021 he had a second CAT scan and it was clear, it was a negative scan. The patient notes that the reason they kept him in the hospital over night was his D-dimer showed numbers that were over 800. He is calling to report his concern that possibly the vaccine may have had something to do with the blood clots, he is not sure but possibly and he wants it on record. The event resulted in Emergency Room visit. Treatment received for the event included he started Eliquis 5mg twice a day for the blood clots while in the hospital. The outcome of event was recovered on 02Sep2021.
The patient received vaccine on 3/25 (2nd dose in series).  The patient was a 911 call  3/31 with death at home (natural causes)   6 days after vaccine receipt
This case was received from a health professional on 08 November 2007. An 82-year-old female patient received an intramuscular left deltoid injection of Fluzone (U2486AA). The patient had a history of hypertension, glaucoma, restless leg syndrome, depression, "factors deficiency", osteoarthritis, increased cholesterol, and "reaction to codeine"; concomitant medications included Niacin, Restoril, Lasix, Hydrochlorothiazide, LoBid, Phenergan, Prinivil, Daypro, Aspirin, Indapamide, and hydralazine. The patient received the injection in the morning of 06 November 2007, and in the evening began experiencing hives and angioedema of the face, neck, and abdomen. She was seen by her physician on 07 November 2007, and treatment included Benadryl 25 - 50 mg every six hours. At the time of the report, the patient had not yet recovered.
pt recv vax 4OCT96 & had lt arm pain following it which attributed to vaccine then devel pain in rt arm  & hips; ESR found to be inc from baseline 26 to 59;had resolution of all pains & accompanying malaise w/in 24hr;
This is a 60-year-old male who comes in today (3/22).  Patient states that he received a Covid shot 11 days ago since then he has had mild fevers.  However 6 days after he received his Covid vaccine he developed a fever of 102 he has been alternating between Advil and Tylenol without any improvement of his symptoms.  Patient states that he now is having a difficult time breathing he has some nausea without any vomiting but has had a difficult time eating without any abdominal pain no diarrhea.  Has had generalized myalgias as well. He denies any large cough states that he is coughing a little bit.  No chest pain.  Patient tested positive for Covid 19. Is now admitted and on oxygen.
Lump under left check on neck, hives face, neck, ears, chest arms etc. going on a week
8/18/21: Admitted for CF exacerbation. tested positive for COVID on 8/19. History of pseudomonas and multidrug-resistant achromobacter culture last year.  COVID exposure a few weeks ago and tested negative for COVID-19 last week, feeling sick for past 2 days with increasing cough and yellow sputum. Previously vaccinated with Pfizer COVID-19 vaccine:  1st vaccine 4/22/2021, second 5/13/2021. Diagnosed with CF exacerbation, COVID-19 pneumonia with hypoxia, bronchiolitis 8/26/21: discharged
This spontaneous report has been received from a registered nurse concerning an unspecified number of patients of unknown age and gender. The patient's concurrent conditions and pertinent medical history were not reported. On an unknown date, the patients were vaccinated with improperly stored doses of ZOSTAVAX lot # L012475, exp. date on 10-JUL-2016, (strength, route of administration and dose were not reported). There was no concomitant medication reported. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
I broke out with shingles 30 hours after I received my Covid Booster (3rd shot) over night the night after my booster. I saw a nurse practitioner on December 9 who gave me a sterroid shot and prescribed Valtrex and topical cream from a local vital compounder. I started having severe internal pain from shingles on December 20 and wound up in the ER. The next day I went back to Clinic because the pain meds given at the ER did not help. I was given a Toradol shot and given Toradol and Lyrica prescriptions. I recovered and was feeling better. Then on January 8, 2022, I started having symtoms of Covid 19. I was tested on January 11 and tested positive. On January 19, 2022 the internal shingle pain returned with a vingance. I ended up back in the ER; this time at Medical Center. I was given an EKG to rule out heart issues since I was hurting in my chest. They gave me Toradol and sent me home with a Toradol prescription and told me to continue the Lyrica I already had. On January 21, 2022, I went back to Clinic because the Toradol and Lyrica were not helping with my pain. I was prescribed a round of steroids and increased my dose of Lyrica along with a second round of Valtrex. I am much better today
PERSON RECEIVED 0.3ML OF THE UNDILUTED VACCINE, NO ADVERSE EFFECT REPORTED @15MIN AND @4HRS
Hives  (NOT immediately after receiving injection and NOT at injection site).  Approximately 36 hours after receiving injection, woke up with hives on buttocks and upper thigh...very itchy.  Went to doctor that day...my primary care physician assistant says this is an atypical reaction.  Began taking Allegra (60 mg. every 12 hours) which cleared the hives.  Stopped about a week later....hives returned in 48 hours.  I have been repeating this cycle of taking Allegra  for a week, then stopping.  Hives continue to appear after about 48 hours every time...it has been four weeks now.  I am NOT prone to getting hives...have only had them twice before in my life.  Once from eating shellfish at age 16.  Once when I found out I am allergic to penicillin (in my 30's)...was diagnosed with serum sickness.  Hives lasted 18 months that time...took a strong antihistamine (Periactin was the name, I believe) to control hives.  This current episode of hives cannot be attributed to any factor other than the Fluzone-high dose injection.  I have not eaten anything out of the ordinary, have not used any new soaps or laundry detergent.   It appears that I may have to take Allegra for many weeks, if not months, before the reaction goes away.
Resident received Covid-19 booster on 7/26 with no signs of reaction noted. On 7/28 resident began to have new onset bilateral lower extremity swelling and 2+ edema, as well as a red, hot, swollen, hard arm at injection site. She also had new onset tremors, and facial redness and slight swelling. Resident was then sent out to ER for evaluation. Resident returned same night and returned with non-productive cough. Resident tested on 7/29 for COVID-19 and resulted positive. Resident stabilized in facility now, managing symptoms.
fever; chills; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA and CHILLS in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA and CHILLS. At the time of the report, PYREXIA and CHILLS outcome was unknown.            Concomitant medication was not provided. Treatment information was not provided.
When I woke up I felt kind of dizzy. A month later I started feeling dizzy and light headed and it hasn't gone away.
I still feel mild pain and stiffness in the left upper arm almost two months after my booster.
Vaccine #1: very mild arm pain for 2 days. Fatigue and exacerbated migraine for 4 days Vaccine #2: severe arm pain for 2 days to the point of causing nausea due to the severity anytime I tried to move my arm and felt as if I had undergone a surgery on it. Significant fatigue 3 days, whole body achiness 3 days, felt as if I had whiplash for 3 days, severe migraine for 1.5 days. Unable to work Thurs/Fri after the vaccine. Now still with ongoing mild fatigue, mildly increased migraine from baseline, sinus congestion/nausea/lack of appetite/intermittent mild sore throat all began 3 days post vaccine and are still present. Intermittent dizziness began 7 days post vaccine and is still occurring.
This spontaneous report as received from a consumer refers to a 65 years old female patient with AUGMENTIN allergic. The patient's medical history included patient tested positive antibody for chickenpox prior to the vaccination. The patient was vaccinated with a dose of ZOSTAVAX (Lot#, dose and route not reported) on 20-JUL-2012. Concomitant medications included: "blood pressure and anginal medications", AMBIEN and vitamins (unspecified). On 21-JUL-2012 the patient developed a lump at the injection site and experienced itchy rash on her ankle, belly and neck after receiving a dose of therapy. BENADRYL pills and cortisone cream were given. The patient sought medical attention by talking to the pharmacist. At the time of reporting, the outcomes were not recovered. Additional information has been requested.
Over baseball size, swollen, red-inflammation, hot to touch, loss of sleep, nausea, chilled
Patient reported pain after flu vaccine was administered, pain has not resolved. Has been treating at Occ Health since 11/15/18- present, treatment has consist of the following: Medrol dose pack, prednisone 20mg po daily x 10days, dexamethasone patch provided through physical therapy.
Vaccine was pulled from freezer and only thawed for 15 mins before administration, not 1 hour per EUA for 5.5ml vial.
Enlarged lymph nodes around left upper quadrant of the armpit and left subclavicle; Enlarged lymph nodes around left upper quadrant of the armpit and left subclavicle; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EAW0161) via an unspecified route of administration in the left arm on 19Apr2021 at 10:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant past medical history. The patient had no known allergies to medications, food or other products. Concomitant medications included prenatal vitamin; taken for unknown indication on an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 29Mar2021 at 10:45 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021 at 10:00, the patient experienced enlarged lymph nodes around left upper quadrant of the armpit and left sub clavicle. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event enlarged lymph nodes around left upper quadrant of the armpit and left subclavicle was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
This case was reported by a healthcare professional to a sales representative and described the occurrence of injection site reaction in a subject of unspecified age and gender who was vaccinated with influenza virus vaccine (Fluarix) for prophylaxis. On an unspecified date in 2006, on or before 03 October 2006, the subject received a dose of Fluarix (site of injection, dose number and lot number not provided). On an unspecified date in 2006, on or before 03 October 2006 less than one year after vaccination with Fluarix, the subject experienced injection site swelling "the size of a baseball". At the time of initial reporting, 03 October 2006, the event was worse. The healthcare professional considered the event was probably related to vaccination with Fluarix.
site of injection swollen, large red area.  Heart beating erratically, erythema,  fluttering, racing, stopping. Brain fog, balance problems.
Information has been received from a medical assistant concerning a male patient who on an unspecified date was vaccinated with PNEUMOVAX 23 (Lot # 665924/0930Z, Exp. Date 17-JUL-2011). On an unspecified date "the patient who came into the office who had redness and swelling looked at". The patient's outcome was unknown. Medical assistant would like a lot check. A lot check has been initiated. A standard lot check investigation has been finalized. All in-process quality checks for the lot number in question were satisfactory. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. Additional information has been requested. This is one of several reports received from the same source.
Wednesday Sept 8th, 24 hours  after the 2nd shot , started to feel weak and pain in the right side and vomiting. went to hospital was given pain medication and sent home. Next day more pain and weakness in the Legs. More pain. a CT scan was done and Dr suspected cholecystitis. That day Friday the 10th more weakness and loss control of urine. ON Saturday September 11th, could not use legs  and no control of urine. fly and check into Hospital. condition continue to get worst and by Tuesday September 14th legs numb, and MRI is performed, the a Spinal Tap, the Tap confirmed the GBS  Guillain-Barre Syndrome. Immediately moved to ICU.  Given  two IVIG treatments in 48 hours. Recover started and PT and OT worked to help. now doing PT 3 times per week and making recovery.
injection site warmth; injection site induration; injection site erythema; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (injection site warmth), VACCINATION SITE INDURATION (injection site induration) and VACCINATION SITE ERYTHEMA (injection site erythema) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (injection site warmth), VACCINATION SITE INDURATION (injection site induration) and VACCINATION SITE ERYTHEMA (injection site erythema). At the time of the report, VACCINATION SITE WARMTH (injection site warmth), VACCINATION SITE INDURATION (injection site induration) and VACCINATION SITE ERYTHEMA (injection site erythema) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Per report, al the events occurred about one week after vaccination.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 25-Mar-2021: Events outcome was updated.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
COVID 19 Treatment; COVID 19 Treatment; Interchange of vaccine products; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 25-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 22Sep2022 at 17:15 as dose number unknown (booster), single (Batch/Lot number: unknown) at the age of 24 years, in left arm for covid-19 immunisation; coviD-19 vaccine nrvv ad26 (jnj 78436735) (JANSSEN COVID-19 VACCINE), in Apr2021 as dose number unknown, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 22Sep2022 at 17:15, outcome "unknown"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2023, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative, notes: 14 days after testing negative for covid and the end of my paxlovid treatment; Positive, notes: I tested positive for covid. Paxlovid was taken as therapeutic measures as a result of drug ineffective, covid-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300253550 Same patient, different drug, different event;
Patient states she had a raised red spot about the size of a nickel around the injection site.  She also had a red area with a 2 inch diameter around the injection site.  And her arm was itchy.  This started a day or two after receiving the vaccine and lasted about a week and a half.
Severe joint pain all over for about 1 hour.  This occured about 1 hour after 2nd dose vaccine had been given.
Patient called on 06-28-2004 complaining of a rash under both arms, upper inner aspects of both arms, and inner thighs.  Patient stated the rash itched, was dry and flaky; had rash for about one week prior to calling.  Described the rash as being circular in shape.  He received HBV #2 on 03/05/2004.  Patient returned to clinic on 07/26/2004 for HBV #3.  He continued to complain of the rash under both inner arms.  He said it itched very little.
Patient awoke and had redness, warmth, soreness, and swelling on the backside of the arm (under the arm, near the axilla, which is the opposite side of arm where vaccine was given). There were no other likely causes of these symtoms besides the vaccine given 2 days prior, according to the patient.
Received influenza and pneumovax at approx. 3 pm 12/21/05 - Developed muscle aches and low grade fever 100-101 po, and H/A at approx 6 pm on 12/21/05. Still has sx's - taking O.T.C. Motrin/Aspirin.
Pt  had fever and pain in abdomen in am day after vaccination, with pain increasing in severity, rushed by ambulance to hospital where  acute appendicitis was diagnosed which resulted in emergency surgery and appendectomy.
Pelvic pain over a period of 3 months along with abnormal spotting. Ultrasound revealed burst ovarian cyst requiring self-monitoring but no treatment as pain and fluid should subside.
Chronic gastrointestinal bleeding,  allergic proctocolitis, food allergy onset, poor weight gain, GERD, diarrhea, mucous in stool, abdominal pain.
Fever about 12 hours after vaccination, headache, myalgias, dizziness, skin sensitivity.
Mom left message for triage nurse 03/01/2021 @ 1102 stating parents noted a small rash to bell and back today @ 1000. Per voicemail, child otherwise normal (eating well, drinking well, peeing, pooping, active). RN left mom a voicemail explaining that in about 5% of the population a mild, pink rash to the trunk is noted that lasts 2-3 days and occurs approximately 7-12 days after the MMR vaccine.  RN advised via voicemail if rash lasts greater than 3 days or turns red to call back to discuss.
Case number PHEH2015US019201, is an initial spontaneous report from a health care professional received on 24 Sep 2015. This report refers to a 54 years old male patient. The patient had a thyroid condition and was allergic to eggs/yolks. Concomitant medications which were over the counter included AMBIEN, ATIVAN, FLONASE and multivitamins. The patient was vaccinated with FLUCELVAX (batch number: 173538) intramuscularly on an unknown date. On an unknown date after vaccination the patient experienced heart palpitations and anaphylaxis. as a result of the reaction the patient took BENADRYL and was stable at the time of this report. Final outcome of the events was unknown. Seriousness and causality of the events were not reported. Seriousness assessment of anaphylaxis was upgraded based on the NVS-IMS list.